Bridge City Capital LLC Purchases 4,235 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Bridge City Capital LLC raised its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 7.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 64,947 shares of the company's stock after acquiring an additional 4,235 shares during the quarter. U.S. Physical Therapy makes up about 1.5% of Bridge City Capital LLC's portfolio, making the stock its 18th largest holding. Bridge City Capital LLC owned about 0.43% of U.S. Physical Therapy worth $5,761,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the business. Bahl & Gaynor Inc. boosted its holdings in U.S. Physical Therapy by 135.4% in the fourth quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company's stock valued at $23,076,000 after acquiring an additional 149,622 shares during the last quarter. State Street Corp lifted its position in shares of U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company's stock worth $56,522,000 after purchasing an additional 99,244 shares during the period. Copeland Capital Management LLC boosted its stake in shares of U.S. Physical Therapy by 9.5% in the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock valued at $74,459,000 after purchasing an additional 72,715 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of U.S. Physical Therapy during the fourth quarter worth $6,240,000. Finally, Southernsun Asset Management LLC raised its stake in U.S. Physical Therapy by 10.5% during the third quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company's stock worth $46,302,000 after buying an additional 52,062 shares during the last quarter.

Remove Ads

Analysts Set New Price Targets

A number of analysts have commented on the stock. Bank of America raised shares of U.S. Physical Therapy from a "neutral" rating to a "buy" rating and upped their price target for the company from $100.00 to $115.00 in a research report on Monday, December 16th. StockNews.com cut U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research note on Friday, February 28th. JMP Securities assumed coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They issued an "outperform" rating and a $113.00 price target on the stock. Citizens Jmp raised shares of U.S. Physical Therapy to a "strong-buy" rating in a research report on Monday, December 16th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Wednesday, March 19th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, U.S. Physical Therapy presently has a consensus rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Stock Down 0.1 %

Shares of NYSE USPH traded down $0.05 during midday trading on Thursday, hitting $72.82. 130,837 shares of the stock traded hands, compared to its average volume of 100,228. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy, Inc. has a one year low of $72.27 and a one year high of $113.63. The business has a 50 day moving average price of $83.58 and a two-hundred day moving average price of $86.63. The company has a market cap of $1.11 billion, a PE ratio of 77.47, a P/E/G ratio of 3.54 and a beta of 1.51.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). The business had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. On average, equities analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be given a $0.45 dividend. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.44. The ex-dividend date is Friday, March 14th. This represents a $1.80 annualized dividend and a yield of 2.47%. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 97.83%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the firm's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.70% of the company's stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.